Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
AbbVie (prior sponsor, Abbott)
With
Eisai Co., Ltd.
Age
19–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Adult patients (19 years and above) with one of the following indications:
* Moderately to severely active rheumatoid arthritis or
* active and progressive psoriatic arthritis when the response to previous disease-modifying anti-rheumatic drug therapy has been inadequate or
* severe active ankylosing spondylitis who have had an inadequate response to conventional therapy or
* severely active Crohn's disease who have had no response, intolerance or contraindication to corticosteroid therapy or immunosuppressants or
* moderately to severely active psoriasis patients who have had no response, have intolerance or have contraindication to systemic therapies including cyclosporine, methotrexate or photochemotherapy (PUVA).
Patients who give verbal or written authorization to use their personal and health data.
You may not be if
\- Patients with known hypersensitivity to adalimumab or any of its excipients.
Clareo Health | Surveillance of Humira Injection in Korean Patients
